CA1036438A - Implant balistique pour animaux - Google Patents

Implant balistique pour animaux

Info

Publication number: CA1036438A
Authority: CA; Canada
Prior art keywords: pro; biologically active; active material; release; ballistic
Prior art date: 1976-02-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA245,049A

Other languages

English (en)

Inventor

Fred R. Paul (Jr.)

James F. Drake (Jr.)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

3M Co

Original Assignee

Minnesota Mining and Manufacturing Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-02-02

Filing date

1976-02-02

Publication date

1978-08-15

1976-02-02 Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co

1976-02-02 Priority to CA245,049A priority Critical patent/CA1036438A/fr

1978-08-15 Application granted granted Critical

1978-08-15 Publication of CA1036438A publication Critical patent/CA1036438A/fr

Status Expired legal-status Critical Current

Links

241001465754 Metazoa Species 0.000 title claims abstract description 46
239000007943 implant Substances 0.000 title claims description 13
239000011149 active material Substances 0.000 claims abstract description 39
238000013268 sustained release Methods 0.000 claims abstract description 20
239000012730 sustained-release form Substances 0.000 claims abstract description 20
239000000463 material Substances 0.000 claims description 30
239000011159 matrix material Substances 0.000 claims description 15
229920000642 polymer Polymers 0.000 claims description 9
-1 glycer-ides Substances 0.000 claims description 8
239000012982 microporous membrane Substances 0.000 claims description 5
108010010803 Gelatin Proteins 0.000 claims description 4
239000008273 gelatin Substances 0.000 claims description 4
229920000159 gelatin Polymers 0.000 claims description 4
235000019322 gelatine Nutrition 0.000 claims description 4
235000011852 gelatine desserts Nutrition 0.000 claims description 4
239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
235000013871 bee wax Nutrition 0.000 claims description 2
239000012166 beeswax Substances 0.000 claims description 2
230000000149 penetrating effect Effects 0.000 claims description 2
239000004033 plastic Substances 0.000 claims description 2
229920003023 plastic Polymers 0.000 claims description 2
239000012530 fluid Substances 0.000 claims 4
150000002894 organic compounds Chemical class 0.000 claims 1
238000011282 treatment Methods 0.000 description 9
229960005486 vaccine Drugs 0.000 description 8
210000001124 body fluid Anatomy 0.000 description 7
239000010839 body fluid Substances 0.000 description 7
238000012360 testing method Methods 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
244000309466 calf Species 0.000 description 5
238000011081 inoculation Methods 0.000 description 5
230000004044 response Effects 0.000 description 5
238000007789 sealing Methods 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
229920002678 cellulose Polymers 0.000 description 4
239000012528 membrane Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
239000004743 Polypropylene Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 3
229940071676 hydroxypropylcellulose Drugs 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000003533 narcotic effect Effects 0.000 description 3
230000035515 penetration Effects 0.000 description 3
229920001155 polypropylene Polymers 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000004677 Nylon Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241000700605 Viruses Species 0.000 description 2
239000013543 active substance Substances 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000007789 gas Substances 0.000 description 2
125000005456 glyceride group Chemical group 0.000 description 2
244000144980 herd Species 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
238000002513 implantation Methods 0.000 description 2
244000144972 livestock Species 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
210000003739 neck Anatomy 0.000 description 2
231100001160 nonlethal Toxicity 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000098 polyolefin Polymers 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
238000005070 sampling Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
241000894007 species Species 0.000 description 2
230000002936 tranquilizing effect Effects 0.000 description 2
239000001993 wax Substances 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
241000736839 Chara Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
206010051497 Rhinotracheitis Diseases 0.000 description 1
241000187392 Streptomyces griseus Species 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229920006127 amorphous resin Polymers 0.000 description 1
239000012164 animal wax Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
239000003822 epoxy resin Substances 0.000 description 1
239000002360 explosive Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
150000002314 glycerols Chemical class 0.000 description 1
239000007952 growth promoter Substances 0.000 description 1
239000003630 growth substance Substances 0.000 description 1
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000003116 impacting effect Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000007794 irritation Effects 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000007726 management method Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
230000001483 mobilizing effect Effects 0.000 description 1
210000004237 neck muscle Anatomy 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
230000000242 pagocytic effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
230000009894 physiological stress Effects 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920000647 polyepoxide Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
238000010008 shearing Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000002195 soluble material Substances 0.000 description 1
238000007614 solvation Methods 0.000 description 1
238000003892 spreading Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
229920005613 synthetic organic polymer Polymers 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Medicinal Preparation (AREA)

CA245,049A 1976-02-02 1976-02-02 Implant balistique pour animaux Expired CA1036438A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA245,049A CA1036438A (fr)	1976-02-02	1976-02-02	Implant balistique pour animaux

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA245,049A CA1036438A (fr)	1976-02-02	1976-02-02	Implant balistique pour animaux

Publications (1)

Publication Number	Publication Date
CA1036438A true CA1036438A (fr)	1978-08-15

Family

ID=4105154

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA245,049A Expired CA1036438A (fr)	1976-02-02	1976-02-02	Implant balistique pour animaux

Country Status (1)

Country	Link
CA (1)	CA1036438A (fr)

1976
- 1976-02-02 CA CA245,049A patent/CA1036438A/fr not_active Expired

Publication	Publication Date	Title
US3948263A (en)	1976-04-06	Ballistic animal implant
US3982536A (en)	1976-09-28	Ballistic inoculation of animals and projectile therefor
US11318293B2 (en)	2022-05-03	Single or multi-dose delivery platform for veterinary applications
US4004565A (en)	1977-01-25	Clip for supplying implant projectiles
US3760804A (en)	1973-09-25	Improved osmotic dispenser employing magnesium sulphate and magnesium chloride
CA2459459A1 (fr)	2003-03-20	Technique d'administration de medicaments
EP1043562A3 (fr)	2001-06-27	Projectile non mortel pour disperser un matériau inhibiteur sur une cible vivante
JPS6270316A (ja)	1987-03-31	デイスク状徐放性組成物
AU763614B2 (en)	2003-07-31	Pellet implant system for immediate and delayed release of antiparasitic drug
Lok et al.	2001	Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis
GB2155335A (en)	1985-09-25	Device for sustained release of medicinal substances
CA1036438A (fr)	1978-08-15	Implant balistique pour animaux
US4760834A (en)	1988-08-02	Clip with rib stop mechanism for supplying projectiles to gun
US6419655B1 (en)	2002-07-16	Method for controlling animal populations utilizing a sterilant projectile
US4174837A (en)	1979-11-20	Drug dispensing apparatus for a hunting arrow
Kreeger	1997	Overview of delivery systems for the administration of contraceptives to wildlife
CA2573653C (fr)	2010-02-02	Emballage et methode d'administration de dose solide d'une puce d'identification electronique et de medicaments
CH630250A5 (en)	1982-06-15	Ballistically implantable shaped body for the controlled release of active substance
CA1036439A (fr)	1978-08-15	Inoculation des animaux par une methode balistique et projectile idoine
DE60118899D1 (de)	2006-05-24	Verpackung und verfahren zur handhabung von festen arzneimitteldosen
GB2099699A (en)	1982-12-15	Device for introducing nutrients and/or therapeutic materials into ruminant animals
Frick et al.	1994	A rat model to study hypercalcemia-induced acute pancreatitis
Amstrup et al.	1981	Immobilizing free-ranging pronghorns with powdered succinylcholine chloride
RU2396068C1 (ru)	2010-08-10	Устройство для дистанционной доставки вакцин и ветеринарных препаратов
WO2001007079A1 (fr)	2001-02-01	Perfectionnements dans l'administration des vaccins